Amplify Weight Loss Drug & Treatment ETF (THNR) Short Interest Ratio & Short Volume $22.55 -0.10 (-0.44%) As of 04:10 PM Eastern Add Compare Share Share Short Interest Stock AnalysisChartHoldingsOwnershipRatingsShort InterestBuy This Stock Amplify Weight Loss Drug & Treatment ETF Short Interest DataAmplify Weight Loss Drug & Treatment ETF (THNR) has a short interest of 100 shares. This marks a -50.00% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.1, indicating that it would take 0.1 days of the average trading volume of 2,910 shares to cover all short positions.Current Short Interest100 sharesPrevious Short Interest200 sharesChange Vs. Previous Month-50.00%Dollar Volume Sold Short$2,140.00Short Interest Ratio0.1 Days to CoverLast Record DateMay 15, 2025Outstanding Shares130,000 sharesPercentage of Shares Shorted0.08%Today's Trading Volume1,281 sharesAverage Trading Volume2,910 sharesToday's Volume Vs. Average44% Short Selling Amplify Weight Loss Drug & Treatment ETF? Sign up to receive the latest short interest report for Amplify Weight Loss Drug & Treatment ETF and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartTHNR Short Interest Over TimeTHNR Days to Cover Over TimeTHNR Percentage of Float Shorted Over Time Amplify Weight Loss Drug & Treatment ETF Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 5/15/2025100 shares $2,140.00 -50.0%N/A0.1 $21.40 4/30/2025200 shares $4,404.00 +100.0%N/A0.1 $22.02 4/15/2025100 shares $2,014.00 -66.7%N/A0.1 $20.14 3/14/2025100 shares $2,247.00 -50.0%N/A0.1 $22.47 2/14/2025100 shares $2,249.00 No ChangeN/A0.1 $22.49 1/31/2025100 shares $2,313.00 -90.9%N/A0.1 $23.13 THNR Short Interest - Frequently Asked Questions What is Amplify Weight Loss Drug & Treatment ETF's current short interest? Short interest is the volume of Amplify Weight Loss Drug & Treatment ETF shares that have been sold short but have not yet been closed out or covered. As of May 15th, investors have sold 100 shares of THNR short. Learn More on Amplify Weight Loss Drug & Treatment ETF's current short interest. Is Amplify Weight Loss Drug & Treatment ETF's short interest increasing or decreasing? Amplify Weight Loss Drug & Treatment ETF saw a decrease in short interest in May. As of May 15th, there was short interest totaling 100 shares, a decrease of 50.0% from the previous total of 200 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Amplify Weight Loss Drug & Treatment ETF's short interest compare to its competitors? Here is how the short interest of companies compare to Amplify Weight Loss Drug & Treatment ETF: ProShares Decline of the Retail Store ETF (0.32%), Tema Luxury ETF (0.50%), ProShares Ultra Nasdaq Cloud Computing ETF (0.11%), iShares Breakthrough Environmental Solutions ETF (0.31%), SPDR MSCI USA Climate Paris Aligned ETF (0.25%), iShares Neuroscience and Healthcare ETF (8.13%), Global X Disruptive Materials ETF (0.82%), First Trust Nasdaq Lux Digital Health Solutions ETF (0.40%), and Gabelli Growth Innovators ETF (0.26%). Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($29.20 billion), Strategy Incorporated ($10.88 billion), iShares 20+ Year Treasury Bond ETF ($10.04 billion), Capital One Financial Co. ($5.51 billion), Charter Communications, Inc. ($5.00 billion), Super Micro Computer, Inc. ($4.43 billion), Apollo Global Management, Inc. ($4.02 billion), Hims & Hers Health, Inc. ($3.65 billion), VanEck Semiconductor ETF ($3.27 billion), and Coinbase Global, Inc. ($3.10 billion). View all of the most shorted stocks. What does it mean to sell short Amplify Weight Loss Drug & Treatment ETF stock? Short selling THNR is an investing strategy that aims to generate trading profit from Amplify Weight Loss Drug & Treatment ETF as its price is falling. THNR shares are trading up $0.00 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Amplify Weight Loss Drug & Treatment ETF? A short squeeze for Amplify Weight Loss Drug & Treatment ETF occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of THNR, which in turn drives the price of the stock up even further. How often is Amplify Weight Loss Drug & Treatment ETF's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including THNR, twice per month. The most recent reporting period available is May, 15 2025. More Short Interest Resources from MarketBeat Related Companies ProShares Decline of the Retail Store ETF Short Squeeze Tema Luxury ETF Short Squeeze ProShares Ultra Nasdaq Cloud Computing ETF Short Squeeze iShares Breakthrough Environmental Solutions ETF Short Squeeze SPDR MSCI USA Climate Paris Aligned ETF Short Squeeze iShares Neuroscience and Healthcare ETF Short Squeeze Global X Disruptive Materials ETF Short Squeeze First Trust Nasdaq Lux Digital Health Solutions ETF Short Squeeze Gabelli Growth Innovators ETF Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NYSEARCA:THNR) was last updated on 6/5/2025 by MarketBeat.com Staff From Our PartnersEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredJunior Explorer Taps Into TSMC’s $165 Billion Chip CorridorThe chip war is moving underground. As the U.S. ramps up semiconductor production to outpace China, an unex...Capital Trends | SponsoredCollect $7k per month from Tesla’s SECRET dividendI just uncovered a strategy that could pay out up to $7,013 every month—without needing a traditional dividend...Investors Alley | SponsoredA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredWhen This Happens, You Don’t Wait. You Act.This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Amplify Weight Loss Drug & Treatment ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Amplify Weight Loss Drug & Treatment ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.